Navigation Links
Thomson Reuters-NPR Health Poll Finds Three in Four Americans Link Narcotic Pain Killers to Drug Addiction
Date:11/22/2011

ANN ARBOR, Mich. and WASHINGTON, Nov. 22, 2011 /PRNewswire/ -- More than three-quarters of Americans believe narcotic pain killers are linked to drug addiction and 59.5 percent associate the drugs with depression, according to the Thomson Reuters-NPR Health Poll.

Thomson Reuters and NPR conduct the monthly poll to gauge attitudes and opinions on a wide range of health issues.

The survey, which asked respondents their opinions and concerns regarding narcotic pain killers, found that 49.7 percent have used these drugs in the past.  Of those, over one-third of respondents said they used the drugs despite having concerns regarding their use.  The top concerns reported were potential side effects (44.9 percent), fear of addiction (27.5 percent) and concern about potential long-term health impacts (15.5 percent).

Among all survey respondents (those who have taken narcotic pain killers and those who have not), 77.2 percent said they believe the use of narcotic pain killers such as Oxycontin, Percocet, Vicodin or morphine can lead to drug abuse and 59.5 percent said they associated the drugs with depression.  Additionally, 30.8 percent of survey respondents said they questioned or refused a physicians recommendation of narcotic pain killers.  Those who have not taken narcotic pain killers in the past cited fear of addiction as their primary concern (38 percent), followed by association with drug abuse (24.8 percent) and side effects (20.8 percent).

"With such a significant number of responders having been prescribed a narcotic pain killer, our results suggest that these drugs are relatively easy to access despite the need for a physician's prescription," said Raymond Fabius, M.D., chief medical officer at the healthcare business of Thomson Reuters. "It's encouraging to see a healthy understanding of the addictive properties of narcotics among our survey population, but refusing to use them when they can be helpful may cause people to experience unnecessary pain."

To date, the Thomson Reuters-NPR Health Poll has explored numerous healthcare topics, including generic drugs, abortion, vaccines, food allergies, and organic and genetically modified foods. NPR's reports on the surveys are archived online at the Shots health blog here: http://www.npr.org/blogs/health/2011/11/22/142601714/when-weighing-painkillers-americans-worry-will-i-become-an-addict?ps=sh_sthdl

Thomson Reuters maintains a library of poll results: http://healthcare.thomsonreuters.com/npr/

The Thomson Reuters-NPR Health Poll is powered by the Thomson Reuters PULSE(SM) Healthcare Survey, an independently funded, nationally representative telephone poll that collects information about health-related behaviors and attitudes and healthcare utilization from more than 100,000 US households annually. Survey questions are developed in conjunction with NPR. The figures in this month's poll are based on 3,009 participants interviewed from October 1-13, 2011. The margin of error is 1.8 percent.

For a copy of the vaccine survey results. visit http://healthcare.thomsonreuters.com/npr/assets/NPR_report_PainKillers.pdf

About Thomson Reuters
Thomson Reuters is the world's leading source of intelligent information for businesses and professionals.  We combine industry expertise with innovative technology to deliver critical information to leading decision makers in the financial, legal, tax and accounting, healthcare and science and media markets, powered by the world's most trusted news organization.  With headquarters in New York and major operations in London and Eagan, Minnesota, Thomson Reuters employs more than 55,000 people and operates in over 100 countries.  For more information, go to www.thomsonreuters.com.

About NPR
NPR is an award-winning, multimedia news organization and an influential force in American life. In collaboration with more than 900 independent public radio stations nationwide, NPR strives to create a more informed public - one challenged and invigorated by a deeper understanding and appreciation of events, ideas and cultures.

 

 

 


'/>"/>
SOURCE Thomson Reuters
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Alabama Selects Thomson Reuters HIE Advantage™ for Statewide Health Information Exchange
2. Thomson Reuters - NPR Health Poll Finds Three-Quarters of Americans Support Government Insurance Subsidies for Birth Control Pills
3. Thomson Reuters Trademark Report Reveals New Challenges and Opportunities for Pharmaceutical Brands
4. Drug Combinations That May Cause Major Drug Interactions Common Among Seniors Who Take Antidepressants, According to Thomson Reuters Research
5. Higher Education Foundation in Brazil Seals Its Continued Relationship with Thomson Reuters for Academic Healthcare Content
6. Asia Pacific Pharma Companies Turning to High-Risk, High-Reward Drug Development, According to New Report from Thomson Reuters
7. Thomson Reuters Unveils Pharmacy Xpert Solution to Improve Medication Management for Hospital Pharmacists
8. Thomson Reuters Releases iPhone Support for Clinical Xpert Navigator
9. Federal Government Selects Thomson Reuters to Build Tool That Streamlines Comparative Effectiveness Research
10. Thomson Reuters Predicts Nobel Laureates
11. Morehead Memorial Hospital Goes Live with Thomson Reuters Clinical Xpert CareFocus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... 2017  IRIDEX Corporation (Nasdaq: IRIX ) ... the first quarter 2017 after the close of trading ... will host a corresponding conference call beginning at 2:30 ... interested in listening to the conference call may do ... (703) 326-3030 for international callers, using conference ID: 92158987.  ...
(Date:4/19/2017)... 19, 2017 Global Prostate Cancer Therapeutics ... the prostate cancer therapeutics market analyzes the current ... prevalence of prostate cancer, launch of promising emerging ... of new drugs & therapeutic biological products, and ... to lesser side effects are some of the ...
(Date:4/19/2017)... PUNE, India , April 19, 2017 ... Type and Application, Forecast to 2022 report has covered and ... provides statistics and information on market size, shares and growth ... with major drivers, challenges and opportunities in the global market. ... Browse 152 Tables and ...
Breaking Medicine Technology:
(Date:4/28/2017)... Manhattan New york (PRWEB) , ... April 28, ... ... is pleased to announce that Aditya Patel M.D. has joined the revolutionary endoscopic ... fellowship training and board certification in Interventional Pain Medicine. The patented, revolutionary eDiscSculpt ...
(Date:4/28/2017)... ... April 28, 2017 , ... People are starting to ... “Wearing a hearing aid doesn’t have the stigma it had when great-grandpa wore his ... of Greater Boston, in a NALA North American Speaker Series (NASS) segment. ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... their work assisting the Brooke Grove Foundation implement a Microsoft Dynamics GP solution ... Solutions, a leading ERP expert that specializes in long-term care, Brooke Grove now ...
(Date:4/28/2017)... ... ... Christie Medical Holdings, Inc. , with its market-leading vein finder ... a leader in infusion therapy and pain management. , Intravenous (IV) therapy plays ... patients receiving a peripheral IV catheter as part of their treatment plan. Many hospitals ...
(Date:4/27/2017)... Minnesota (PRWEB) , ... April 27, 2017 , ... ... and her husband Dan Gasby the 2017 Public Leadership in Neurology Award (PLINA). ... Woodruff, retired professional athlete Tedy Bruschi, Vice President Walter Mondale, actor Michael J. ...
Breaking Medicine News(10 mins):